Trademark: 75321297
Word
Status
Dead
Status Code
606
Status Date
Friday, May 12, 2000
Serial Number
75321297
Mark Type
2R15
Filing Date
Tuesday, July 8, 1997
Published for Opposition
Tuesday, February 16, 1999
Abandoned Date
Friday, May 12, 2000

Trademark Owner History
PHARMAPRINT INC. - Owner At Publication
PharmaPrint Inc. - Original Applicant

Classifications
5 pharmaceuticals and pharmaceutical preparations based on natural medicines that; reduce the symptoms of premenstrual stress (PMS), regulate the menstrual cycle, increase the production of milk in a woman who is breast feeding, and alter the amounts of the hormone that causes the production of breast milk; cause significant diarrhea, improve wound healing, reduce inflammation, reduce itching, protect the liver and are used in the treatment of arthritis; reduce diarrhea and inflammation; reduce the discomfort of painful menstrual periods, reduce muscle and joint pain and throat soreness, cause sleepiness and are therapy for bronchitis; reduce cramping pain, digestive tract distress and inflammation of the skin; improve hemorrhoids, swelling due to some causes of insufficient blood flow in veins (venous insufficiency), and varicose veins; increase resistance to infections caused by bacteria, improve the healing of superficial skin wounds, and assist the treatment of recurring infections of the respiratory and urinary tracts; promote the flow in menstruation and reduce cramping pain; reduce certain types of skin outbreaks (eczema), reduce the pain of migraine headaches and menstrual periods, and are used in the treatment of asthma and arthritis; reduce certain fatty substances in the blood, including triglycerides and cholesterol; reduce the stickiness of platelets and clotting; and increase the breakdown of blood clots; reduce nausea by acting on the digestive tract; are used in the treatment of inadequate blood flow in vessels in the extremities, including cramping pain in the calf caused by walking, and in the brain; of ringing of the ears; and of abnormal changes in the light sensing portion of the eye, i.e., retina; reduce stress and damage caused to the liver; increase sexual appetite; are used in the treatment of cancer; and are a general tonic; reduce cholesterol levels in the blood and increase the length of one's life; improve heart function, heart conditions associated with the elderly, mild heart pain brought on by exertion (angina), and mild irregularities of the heart beat; and lower blood pressure; are used in the treatment of degenerative arthritis; reduce distress of the intestinal tract; cause sleepiness and treats insomnia; are used in the treatment of ulcers; reduce inflammation; protect the liver, including against scarring (cirrhosis) and inflammation (hepatitis); are a free radical scavenger and antioxidant; reduce pain and inflammation and improve insomnia and bronchial asthma; improve urination, are used in the treatment of non-cancerous enlargement of the male prostate gland, and help rid the body of worms; improve disorders of the male prostate gland, including non-cancerous enlargement; promote the flow in menstruation; are used in the treatment of cancer and diabetes; and in some ways act like an antioxidant; reduce the symptoms caused by non-cancerous enlargement of the male prostate gland; lower blood pressure; stimulate the body's immune system; and reduce stress from environmental factors; improve mild to moderate mood depression; help in AIDS; increase resistance to infections caused by bacteria and viruses; help protect a developing fetus against damage from exposure to drugs, chemicals and certain other materials; stimulate the body's immune system; help the body remove excess fluid through urination; improve rheumatism; and stimulate the growth of hair; promote calm; modify the activity of the body's immune system; improve the clearing of mucous from the lung; treat immunodeficiencies
40 pharmaceutical manufacturing to the order and specifications of others
42 pharmaceutical research; medical research in the nature of identifying and quantifying the active and effective components of natural medicines so that pharmaceutical versions can be made and tested

Trademark Events
Aug 2, 2002
Paper Received
Oct 19, 2000
Abandonment - No Use Statement Filed
Apr 15, 2000
Extension 1 Granted
Nov 8, 1999
Extension 1 Filed
Apr 15, 2000
Reinstated
Oct 19, 2000
Abandonment - No Use Statement Filed
May 11, 1999
Noa Mailed - Sou Required From Applicant
Feb 16, 1999
Published For Opposition
Jan 15, 1999
Notice Of Publication
Nov 4, 1998
Approved For Pub - Principal Register
Nov 4, 1998
Assigned To Examiner
Oct 9, 1998
Examiner's Amendment Mailed
Oct 2, 1998
Examiner's Amendment Mailed
Oct 2, 1998
Previous Allowance Count Withdrawn
Sep 18, 1998
Notice Of Publication
Jul 24, 1998
Approved For Pub - Principal Register
Jun 17, 1998
Examiner's Amendment Mailed
Apr 20, 1998
Correspondence Received In Law Office
Feb 11, 1998
Non-Final Action Mailed
Feb 6, 1998
Assigned To Examiner

Trademark Alertz updated from USPTO on 2030-01-24